Nicholas Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.9M Hold
69,981
1.54% 12
2026
Q1
$64.4M Sell
69,981
-7,348
-10% -$7.45M 1.26% 24
2025
Q4
$83.1M Sell
77,329
-21,185
-22% -$20.3M 1.46% 11
2025
Q3
$75.2M Buy
98,514
+6,500
+7% +$4.84M 1.28% 16
2025
Q2
$71.7M Buy
92,014
+7,940
+9% +$6.17M 1.2% 24
2025
Q1
$69.4M Buy
84,074
+11,489
+16% +$9.56M 1.2% 22
2024
Q4
$56M Sell
72,585
-4,680
-6% -$3.88M 0.91% 40
2024
Q3
$68.5M Sell
77,265
-4,510
-6% -$4.05M 1.11% 31
2024
Q2
$74M Sell
81,775
-2,290
-3% -$1.83M 1.23% 17
2024
Q1
$65.4M Sell
84,065
-15,020
-15% -$10.7M 1.08% 32
2023
Q4
$57.8M Sell
99,085
-10
-0% -$5.84K 1.02% 37
2023
Q3
$53.2M Sell
99,095
-13,005
-12% -$6.7M 1.07% 31
2023
Q2
$52.6M Hold
112,100
1.01% 37
2023
Q1
$38.5M Hold
112,100
0.78% 54
2022
Q4
$41M Sell
112,100
-35
-0% -$12.4K 0.88% 46
2022
Q3
$36.3M Sell
112,135
-4,355
-4% -$1.38M 0.83% 46
2022
Q2
$37.8M Sell
116,490
-11,745
-9% -$3.53M 0.82% 46
2022
Q1
$36.7M Sell
128,235
-54,570
-30% -$14M 0.66% 58
2021
Q4
$50.5M Sell
182,805
-100
-0.1% -$25.4K 0.82% 47
2021
Q3
$42.3M Sell
182,905
-48,175
-21% -$11.9M 0.74% 53
2021
Q2
$53M Sell
231,080
-100
-0% -$20.1K 0.93% 40
2021
Q1
$43.2M Sell
231,180
-1,400
-0.6% -$274K 0.81% 43
2020
Q4
$39.3M Buy
232,580
+50,820
+28% +$7.59M 0.74% 48
2020
Q3
$26.9M Sell
181,760
-15,340
-8% -$2.37M 0.57% 59
2020
Q2
$32.4M Sell
197,100
-82,380
-29% -$12.6M 0.74% 48
2020
Q1
$38.8M Sell
279,480
-68,845
-20% -$9.46M 1.1% 24
2019
Q4
$45.8M Buy
348,325
+53,950
+18% +$6.25M 0.96% 32
2019
Q3
$32.9M Buy
+294,375
New +$32.8M 0.74% 45

Other funds holding LLY

Nicholas Company's LLY Position: Q2 2026 in Review

Nicholas Company held its Eli Lilly (LLY) position steady in Q2 2026 at 69,981 shares worth $83.9M. The position accounts for 1.54% of the portfolio, ranked #12.

Nicholas Company first reported a position in LLY in Q3 2019 and has held it in 28 quarters since. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nicholas Company held 69,981 shares of Eli Lilly worth $83.9M as of Q2 2026.
  • Nicholas Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 1.54% of Nicholas Company's portfolio in Q2 2026, its #12 holding.
  • Nicholas Company first reported a position in Eli Lilly in Q3 2019 and has held it in 28 quarters since.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.